Number of trials | Number of data points included | Median notional cost for total primary outcome collection [min–max] | IQR notional cost for total primary outcome collection [lower limit–upper limit] | Median notional cost for total secondary outcome collection [min–max] | IQR notional cost for total secondary outcome collection [lower limit–upper | Median notional total cost for total data collection [min–max] | IQR notional cost for total data collection [lower limit–upper | |
---|---|---|---|---|---|---|---|---|
All included trials with full Time to collect data | 134 | 134 | £1319.50 [£0–£252,654.13] | £5307.09 [£4525.09–£14,049.72] | £4482.57 [£0–£31,899,140.70] | £14,329.35 [£12,566.10–£37,586.61] | £8015.73 [£52.90–£31,899,140.70] | £20,096.64 [£17,091.62–£53,246.62] |
Phase III | 100 | 100 | £1263.66 [£0–£252,654.13] | £3010.85 [£2242.36–£8295.60] | £3912.06 [£0–£31,899,140.70] | £11,430.02 [£9696.16–£30,308.92] | £7096.30 [£122.25–£31,899,140.70] | £16,581.51[£13,832.45–£44.202.82] |
Core outcome set | 17 | 17 | £979.58 [£0–£47,131.67] | £4073.11 [£3660.51–£10,595.37] | £3712.62 [£35.27–£29,622.60] | £7449.93 [£6108.09–£19,966.65] | £8901.67 [£52.90–£48,295.42] | £21,119.82 [£19,362.44–£54,556.91] |
Public health | 17 | 17 | £8319.21 [£160.65–£142,301.33] | £17,599.59 [£15,831.05–£45,767.50] | £11,852.96 [£213.94–£176,995.04] | £38,481.17 [£33,786.22–£100,897.87] | £20,043.45 [£427.88–£252,850.05] | £36,841.15 [£17,207.36–£111,736.67] |